Formulation and evaluation of nanoparticulate ofloxacin ophthalmic gel using ionic gelation method

B. Salman, Mirza Abdul Hannan Baig
{"title":"Formulation and evaluation of nanoparticulate ofloxacin ophthalmic gel using ionic gelation method","authors":"B. Salman, Mirza Abdul Hannan Baig","doi":"10.33974/ijrpst.v1i2.148","DOIUrl":null,"url":null,"abstract":"Oflaxacin is an ophthalmic and topical anti-bacterial agent used in the management of Allergic conjunctivitis, Trachoma, Blepharitis. The basic idea behind the development of such a system is to maintain a sustained drug release from the dosage form. Oflaxacin is suitable candidate for formulation into sustained dosage form in order to prolong the release of drug. The drug-excipient compatibility studies were carried out by using FTIR technique. Based on the results, excipients were found to be compatible with ofloxacin. In preformulation study, estimation of Ofloxacin was carried out by systronics UV spectrophotometer at λmax 284nm using distilled water, which had a good reproducibility and this method was used in entire study. Formulation was prepared by using ionic gelation method .The response drug content, entrapment efficiency, diffusion, spreadability, In vitro drug release was evaluated Drug content ranging from to 82.6 % to 91.24% entrapment efficiency values are ranged from 91.25% to 94.02% and in -vitro drug release studies are also studied. The In-vitro drug release study of Ofloxacin was carried out by using In-vitro diffusion apparatus.100ml of using tear fluid was taken in a beaker. The solution was stirred with 100rpm by maintaining the temperature of 37˚c ± 5˚c. The drug release data were explored for this type of release mechanism followed. The best fit with the highest determination R2 coefficients was shown by both the models (zero and peppas) followed by Higuchi model which indicate the drug release via diffusion mechanism. However as indicated by the values of R both of the models (zero and peppas) followed by Higuchi model were found to be efficient in describing the release of Ofloxacin.","PeriodicalId":14281,"journal":{"name":"International Journal of Research in Pharmaceutical Sciences and Technology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Research in Pharmaceutical Sciences and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33974/ijrpst.v1i2.148","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Oflaxacin is an ophthalmic and topical anti-bacterial agent used in the management of Allergic conjunctivitis, Trachoma, Blepharitis. The basic idea behind the development of such a system is to maintain a sustained drug release from the dosage form. Oflaxacin is suitable candidate for formulation into sustained dosage form in order to prolong the release of drug. The drug-excipient compatibility studies were carried out by using FTIR technique. Based on the results, excipients were found to be compatible with ofloxacin. In preformulation study, estimation of Ofloxacin was carried out by systronics UV spectrophotometer at λmax 284nm using distilled water, which had a good reproducibility and this method was used in entire study. Formulation was prepared by using ionic gelation method .The response drug content, entrapment efficiency, diffusion, spreadability, In vitro drug release was evaluated Drug content ranging from to 82.6 % to 91.24% entrapment efficiency values are ranged from 91.25% to 94.02% and in -vitro drug release studies are also studied. The In-vitro drug release study of Ofloxacin was carried out by using In-vitro diffusion apparatus.100ml of using tear fluid was taken in a beaker. The solution was stirred with 100rpm by maintaining the temperature of 37˚c ± 5˚c. The drug release data were explored for this type of release mechanism followed. The best fit with the highest determination R2 coefficients was shown by both the models (zero and peppas) followed by Higuchi model which indicate the drug release via diffusion mechanism. However as indicated by the values of R both of the models (zero and peppas) followed by Higuchi model were found to be efficient in describing the release of Ofloxacin.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
离子凝胶法制备纳米氧氟沙星眼用凝胶及评价
氧氟沙星是一种眼用和局部抗菌药物,用于治疗过敏性结膜炎、沙眼、睑缘炎。开发这种系统背后的基本思想是保持药物从剂型中持续释放。为延长药物释放时间,氧氟沙星适宜配制成持续剂型。用FTIR技术进行了药物与赋形剂的配伍研究。根据实验结果,辅料与氧氟沙星配伍。在处方前研究中,利用蒸馏水在λmax 284nm处用系统紫外分光光度计对氧氟沙星的含量进行了测定,该方法重复性好,适用于整个研究。采用离子凝胶法制备了该制剂,并对其药效含量、包封效率、扩散、展布性、体外释放度进行了评价。药物含量范围为82.6% ~ 91.24%,包封效率范围为91.25% ~ 94.02%,并对其体外释放进行了研究。采用体外扩散仪对氧氟沙星进行体外释药研究。在烧杯中取100毫升泪液。在37℃±5℃的温度下,以100rpm的转速搅拌。通过对药物释放数据的研究,探索其释放机制。两种模型(0和peppas)均具有最高的决定R2系数,其次为Higuchi模型,表明药物通过扩散机制释放。然而,从R值可以看出,以Higuchi模型为后的两个模型(0和peppas)都能有效地描述氧氟沙星的释放。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Novel Approaches to Enhance Oral Bioavailability of Poorly Soluble Drugs Formulation, optimization and characterization of Betaxolol hydrochloride proniosomes using 3-2 factorial design Formulation and in-vitro evaluation of niosomal drug delivery system for aceclofenac. Formulation and evaluation of fast disintegrating tablets of metoprolol succinate using various superdisintegrants Formulation and evaluation of nanoparticulate ofloxacin ophthalmic gel using ionic gelation method
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1